All News

People with EGFR+ NSCLC whose disease spread outside the brain after treatment with Tagrisso lived longer when they kept taking Tagrisso along with chemo.

A combination of Iza-bren and Tagrisso showed beneficial results as an initial treatment for advanced/metastatic EGFR-mutated non–small cell lung cancer.

Never-smoker Leah Phillips, co-founder of the Young Lung Cancer Initiative, raises awareness that anyone with lungs can develop lung cancer.

Data from the AQUILA study support the use of fixed-duration subcutaneous Darzalex Faspro as an early treatment option in high-risk smoldering myeloma.

Results from the phase 3 VERONA trial were presented at the 2025 Society of Hematologic Oncology Annual Meeting.

Your diagnosis of an early-stage blood cancer, such as a MPN or MDS, means that something has changed in the way your bone marrow produces blood cells.

Here is an overview of cancers including bladder cancer, kidney cancer and testicular cancer.

This comprehensive guide provides essential information to help patients and their families navigate their prostate cancer journey.

Colorectal cancer is a complex disease. Understanding its fundamental aspects can empower you to have more informed and productive conversations with your oncologist.

Rising colorectal cancer rates in younger adults are prompting earlier screenings, with colonoscopy offering both detection and prevention.

Leaving a legacy is essential for many, especially for those who have faced cancer. We long for our friends and family to understand how cancer impacts our lives.

How can colonoscopy detect colorectal cancer early and prevent it by removing polyps, compared with other noninvasive screening methods?

TAR-200 eliminated tumors in 82% of patients in a phase 2 trial for patients with high-risk non-muscle-invasive bladder cancer.

GLP-1a treatment in patients with polycythemia vera was linked to significant reductions in mortality, disease progression, and serious complications.

As we head into Fall, I’ve been thinking about how much this season represents my daughter’s cancer experience for me.

PredicineCARE, a urine-based test, is under FDA review as a companion diagnostic for bladder cancer, building on previous data and biomarker insights.

CURE spoke with the author of “Between Two Kingdoms” and “The Book of Alchemy” about the latest chapter in her cancer journey.

The FDA granted two fast track designations to TT125-802, an investigational therapy, for the treatment of advanced/metastatic non-small cell lung cancer.

Advances in leukemia treatment now include targeted drugs, lighter chemotherapy and combination regimens that improve tolerance and reduce resistance.

Dr. David A. Taub discussed why Prostate Cancer Awareness Month marks a time to highlight early detection and evolving treatment in an interview with CURE.

Through exercise, meditation, and gratitude, I reset my mind and body, finding peace and strength in life after my cancer diagnosis.

In observation of Leukemia Awareness Month in September, CURE spoke with an expert about basics of the disease.

The FDA granted breakthrough device designation to the Haystack MRD test, which uses ctDNA to detect residual or recurrent stage 2 colorectal cancer.

Patients can best advocate for themselves by asking questions and remembering they have the right to be active participants in their care.

Dr. Paul Gellhaus says PSA testing and modern biopsy methods ease fears and reassure patients, making early prostate cancer detection safe and valuable.

CURE spoke with Dr. Ryan Kahn of Miami Cancer Institute for Ovarian Cancer Awareness Month.

In August 2025, the FDA approved various anti-cancer treatments across a range of disease types, such as colorectal, lung cancer and brain cancer.

For me, standing up to cancer means honoring my wife’s melanoma journey by raising awareness, supporting early detection and research.